inseption videos

  1. Does The Feasibility Process Differ For Rare Diseases? 6/13/2024

    Mimi Ermens, senior director, clinical development operations, global feasibility and start-up support, at CSL Behring answers a question from the audience about whether there is a difference in how you should approach the feasibility process when dealing with rare diseases vs. common diseases.

  2. A Data Scientist's Opinion On Clinical Trial Feasibility 6/13/2024

    How do we define success in the clinical trial feasibility process? Monica Jain, director, R&D data science, Johnson & Johnson Innovative Medicine has a data science background and chimes in with her opinion.

  3. What Data Needs To Be Shared? 6/13/2024

    Nick Palumbo of Takeda explains that with feasibility in clinical trials, it has to be a “two-way street” between the sponsor and sites. He and Mimi Ermens (CSL Behring) talk about the types of questions that need to be asked and the kinds of data that needs to be shared by each stakeholder.

  4. How To Be More Proactive With Feasibility 6/13/2024

    Monica Jain of J&J Innovative Medicine talks about how technologies, real-time monitoring, and performance-based metrics have helped improve the feasibility process and make it more proactive.

  5. How Can We Improve Clinical Trial Feasibility Processes? 5/30/2024

    Inefficient. Time-consuming. Frustrating. Often, these are the words used to describe the feasibility and site selection process for clinical trials. In this Clinical Leader Live, experts from J&J Innovative Medicines, Takeda, and CSL Behring discuss how they’ve improved the feasibility assessment process.

  6. The Synergistic Role Of Drug Safety In Clinical Trial Operations 4/25/2024

    Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.

  7. A Deeper Dive On Mitigating Financial Risk Before Selecting A Vendor 1/23/2024

    In part two of this webinar series, presenters focus on avoiding potential risks, such as unexpected budget changes and unplanned change orders, that could jeopardize the success of a clinical trial.

  8. ICH E6(R3): Practical Steps For Implementation 12/14/2023

    Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.

  9. Mitigating Financial Risk Before Selecting An Outsourcing Vendor 9/25/2023

    Gain insight from several clinical operations experts into the significance of meticulous contract examination when choosing an outsourcing partner.

  10. Trial Control Arms - Best Practices 8/2/2023

    Mitchell Katz, SVP, global clinical operations, has “been there, done that,” when it comes to making decisions about trial control arms, which comparator to use, or the number of patients needed in a first-in-class drug development program. Katz shares his process and thinking here.